Question: Problem 2-32 Spreadsheet Problem: Statement of Cash Flows (LG2-5) Use the balance sheet and income statement below: VALIUMS MEDICAL SUPPLY CORPORATION Balance Sheet as of
Problem 2-32 Spreadsheet Problem: Statement of Cash Flows (LG2-5)
Use the balance sheet and income statement below:
| VALIUMS MEDICAL SUPPLY CORPORATION | |||||
| Balance Sheet as of December 31, 2024 and 2023 | |||||
| (in millions of dollars) | |||||
| Assets | 2024 | 2023 | Liabilities and Equity | 2024 | 2023 |
|---|---|---|---|---|---|
| Current assets: | Current liabilities: | ||||
| Cash and marketable securities | $ 71 | $ 70 | Accrued wages and taxes | $ 48 | $ 40 |
| Accounts receivable | 195 | 180 | Accounts payable | 150 | 140 |
| Inventory | 320 | 290 | Notes payable | 130 | 130 |
| Total | $ 586 | $ 540 | Total | $ 328 | $ 310 |
| Fixed assets: | Long-term debt | $ 576 | $ 554 | ||
| Gross plant and equipment | $ 1,070 | $ 880 | Stockholders equity: | ||
| Less: Accumulated depreciation | 144 | 112 | Preferred stock (6 thousand shares) | $ 6 | $ 6 |
| Net plant and equipment | $ 926 | $ 768 | Common stock and paid-in surplus (100 thousand shares) | 120 | 120 |
| Other long-term assets | 132 | 132 | Retained earnings | 614 | 450 |
| Total | $ 1,058 | $ 900 | Total | $ 740 | $ 576 |
| Total assets | $ 1,644 | $ 1,440 | Total liabilities and equity | $ 1,644 | $ 1,440 |
| VALIUMS MEDICAL SUPPLY CORPORATION | ||
| Income Statement for Years Ending December 31, 2024 and 2023 | ||
| (in millions of dollars) | ||
| 2024 | 2023 | |
|---|---|---|
| Net sales | $ 890 | $ 800 |
| Less: Cost of goods sold | 388 | 351 |
| Gross profits | $ 502 | $ 449 |
| Less: Other operating expenses | 46 | 40 |
| Earnings before interest, taxes, depreciation, and amortization (EBITDA) | $ 456 | $ 409 |
| Less: Accumulated depreciation | 32 | 30 |
| Earnings before interest and taxes (EBIT) | $ 424 | $ 379 |
| Less: Interest | 47 | 41 |
| Earnings before taxes (EBT) | $ 377 | $ 338 |
| Less: Taxes | 79 | 71 |
| Net income | $ 298 | $ 267 |
| Less: Preferred stock dividends | $ 6 | $ 6 |
| Net income available to common stockholders | $ 292 | $ 261 |
| Less: Common stock dividends | 128 | 128 |
| Addition to retained earnings | $ 164 | $ 133 |
| Per (common) share data: | ||
| Earnings per share (EPS) | $ 2.92 | $ 2.61 |
| Dividends per share (DPS) | $ 1.28 | $ 1.28 |
| Book value per share (BVPS) | $ 7.34 | $ 5.70 |
| Market value (price) per share (MVPS) | $ 8.37 | $ 6.18 |
Prepare a statement of cash flows for Valiums Medical Supply Corporation.
Note: Enter your answers in millions of dollars. Amounts to be deducted should be indicated with a minus sign.
| Statement of Cash Flows for Year Ending December 31, 2024 | |
| (in millions of dollars) | |
| Cash flows from operating activities | |
| Additions (sources of cash): | |
| Subtractions (uses of cash): | |
| Net cash flow from operating activities | |
| Cash flows from investing activities | |
| Subtractions: | |
| Net cash flow from investing activities | |
| Cash flows from financing activities | |
| Additions: | |
| Subtractions: | |
| Net cash flow from financing activities | |
| Net change in cash and marketable securities | |
*Please fill in all blanks for statement of cash flows.
Step by Step Solution
There are 3 Steps involved in it
Get step-by-step solutions from verified subject matter experts
